Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic Saline Bath in Cancer
NCT04210726Withdrawn
- Start
- Mar 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Randomised, open-label trial of sodium chloride in cancer. Primary endpoint: Reduction in Tumors size at 6 months. Planned start Mar 2020; status: withdrawn.
02
Drugs
sodium chloride
03
Conditions
cancer
Beyond the preview
Go deeper on NCT04210726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04210726.